Physiotherapy Is Fastest Growing Segment Fueling The Growth Of Complex Regional Pain Syndrome Market

The global Complex Regional Pain Syndrome Market is estimated to be valued at US$ 103.7 Mn in 2023 and is expected to exhibit a CAGR of 2.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Complex regional pain syndrome (CRPS) is a chronic pain condition that usually affects an arm or leg. It can sometimes also affect other parts of the body. It causes persistent severe and burning pain that is disproportionate to any inciting event. Physiotherapy and medications play an important role in managing CRPS symptoms.

Market key trends:
One of the major trends in the complex regional pain syndrome market is the increasing focus on physiotherapy as a treatment approach. Physiotherapy helps to relieve pain and prevent further disability by improving movement and function. Techniques such as mirror therapy are becoming increasingly popular for CRPS treatment. Mirror therapy uses a mirror to trick the brain into thinking the affected limb is moving normally again. This promotes neural rewiring and helps reduce pain.

Segment Analysis
The global complex regional pain syndrome market is segmented into two categories- type and end user. By type, the market is divided into type I and type II. Type I CRPS is the dominating segment owing to increased susceptibility of the condition to appear after trauma or injury without major nerve damage. Type I CRPS accounts for over 60% of the total market share due to the rising prevalence of the condition post limb fractures or sprains.

By end user, the market is classified into hospitals, clinics, ambulatory surgical centers, and others. Hospitals dominate the end-user segment owing to high patient footfall for CRPS diagnosis and availability of advanced treatment facilities.

Key Takeaways
The Global Complex Regional Pain Syndrome Market Size is expected to witness high growth, exhibiting a CAGR of 2.2% over the forecast period, due to the increasing prevalence of chronic pain disorders.

The North American region dominates the market and is expected to maintain its lead over the forecast period. This is attributed to the rising prevalence of CRPS, developed healthcare infrastructure, availability of advanced treatment options in the region, and increasing healthcare spending.

Key players operating in the complex regional pain syndrome market are Boston Scientific Corporation, GlaxoSmithKline plc., Johnson & Johnson, Viatris, Sanofi S.A, and Medtronic Plc. Boston Scientific holds the major market share due to its diverse portfolio of neurostimulation devices for treating CRPS.

For More Insights, Read: https://www.newsstatix.com/complex-regional-pain-syndrome-market-size-share-and-growth-forecast-2023-2030/